Five teams of MBA Students and healthcare and biotechnology innovators will pitch their business commercialization plans live on stage to a panel of experts for a chance to win over $10,000 in prizes at the MaRS Discovery District on Dec 6.
The newly chosen top three teams will then make their final presentation about their business technology and compete for the grand prize.
This challenge awards the commercialization plans most likely to get healthcare products and services out of labs and into commercial markets. Sponsors include pharmaceutical companies Sanofi Pasteur, Dalton Pharma Services, the Ontario Centres of Excellence [OCE], York Region, The Ontario Research and Innovation Optical Network [ORION] RBC and Bereskin & Parr-Intellectual Property Law lawyers.
This 6th annual Sanofi Pasteur Healthcare & Biotechnology Venture Challenge 2012 final pitch is set for Thursday, Dec 6, 8:00 A.M.-2:00 P.M., at the MaRS Discovery District, MaRS Centre South Tower, Suite 100, 101 College Street in Toronto.
The five finalists are:
*Data And Technology Solutions: online data analysis & collaboration decision system for Ontario’s Health Service Providers
*Lumasonix: proprietary medical imaging device which detects breast cancer in early clinical stages
*Syngamma Therapeutics: commercializing proprietary biotech for therapeutic for breast, colon, stomach and pancreatic drugs
*SenoSENSE Medical Systems: identifies women at elevated risk for breast cancer at point of care by measuring their breast density
*TrendyMED: small light weight infusion device which delivers IV liquids to patients from any size bag without the need for gravity and poles